Company Analysis

Medicinova Inc (MNOV)

Nasdaq: MNOV · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2003
Grade5.6
◀ Past 4.8● Present 6.8▶ Future 5.0
2 est.

Who owns Medicinova Inc

As filed with the SEC
Holders of 5% or more
1
3D Investment Partners Pte. Ltd. holds 9.9% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D/A filed Sep 29, 2026 says.
Directors and officers
5
report now, of 15 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
3D Investment Partners Pte. Ltd.
SCHEDULE 13D/A · filed Sep 29, 2026 · Common Stock, par value $0.001 per share
9.9%
What MNOV reports owning in othersstakes of 5% or more, and other ties

4 subsidiaries in 4 countries, from the list filed with the 10-K/A filed Mar 28, 2023.

Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
1617202122
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 17 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
3d Opportunity Master Fund10% owner1$1.7M00$0
SI Assistanton MNOV · research, not advice